SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-173696
Filing Date
2021-05-26
Accepted
2021-05-26 16:59:02
Documents
11
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 6-K d122172d6k.htm 6-K 12962
2 EX-99.1 d122172dex991.htm EX-99.1 67183
3 EX-99.2 d122172dex992.htm EX-99.2 31563
4 EX-99.3 d122172dex993.htm EX-99.3 5400
5 EX-99.4 d122172dex994.htm EX-99.4 7825
6 GRAPHIC g122172dsp06.jpg GRAPHIC 7657
7 GRAPHIC g122172g04c53.jpg GRAPHIC 119725
8 GRAPHIC g122172g0525022439146.jpg GRAPHIC 2798
9 GRAPHIC g122172g0525022439474.jpg GRAPHIC 1610
10 GRAPHIC g122172g0525022520329.jpg GRAPHIC 2910
11 GRAPHIC g122172g71j49.jpg GRAPHIC 118662
  Complete submission text file 0001193125-21-173696.txt   475907
Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40299 | Film No.: 21967157
SIC: 2836 Biological Products, (No Diagnostic Substances)